Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Cambridge Nutritional Science (CNSL) by Steve Moore in ShareProphets
- Buy Vesuvius (VSVS) by Jefferies
- Buy Water Intelligence (WATR) by Hot Stock Rockets in ShareProphets
- Hold Hilton Food Group (HFG) by Peel Hunt
- Buy M&G (MNG) by Simon Watkins in The Motley Fool
- Buy Linde (0M2B) by UBS
- Sell Croda International (CRDA) by Goldman Sachs
- Sell Ashmore Group (ASHM) by Deutsche Bank
- Outperform 3i Infrastructure (3IN) by RBC Capital
- Hold Tullow Oil (TLW) by Shore Capital
- Buy Applied Nutrition (APN) by Deutsche Bank
- Buy Pennon Group (PNN) by Deutsche Bank
- Buy United Utilities Group (UU.) by Deutsche Bank
- Buy Currys (CURY) by Deutsche Bank
- Buy Rightmove (RMV) by Deutsche Bank
- Hold Severn Trent (SVT) by Deutsche Bank
- Outperform Barclays (BARC) by RBC Capital
- Buy Compass Group (CPG) by Goldman Sachs
- Equal Weight Associated British Foods (ABF) by Barclays
- Overweight Wise Class A (WISE) by JP Morgan
Synairgen (SNG) Share Price
Health Care Sector
NOTE: This is based on 29 open tips for Synairgen (SNG)
| Latest Bid : 0.60p | Latest Ask : 1.20p |
| High Today : 1.28p | Low Today : 0.70p |
| This Years High : 5.46p | This Years Low : 0.70p |
| Volume : 1,625,837 | MKT Cap : £1.92M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Synairgen (SNG) Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.Synairgen (SNG) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-05-07 06:48:00 07/05/2024 | -84.68% |
| Hold | Richard Evans | Premium Only | 2021-11-10 07:45:00 10/11/2021 | -97.43% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-10-20 11:20:00 20/10/2021 | -97.12% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-06-16 14:25:00 16/06/2021 | -96.55% |
| Watch | Richard Evans | Premium Only | 2021-06-02 08:25:00 02/06/2021 | – |
Synairgen (SNG) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.60p | Latest Ask : 1.20p |
| High Today : 1.28p | Low Today : 0.70p |
| This Years High : 5.46p | This Years Low : 0.70p |
| Volume : 1,625,837 | MKT Cap : £1.92M |
Synairgen Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Synairgen Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-05-07 06:48:00 07/05/2024 | -84.68% |
| Hold | Richard Evans | Premium Only | 2021-11-10 07:45:00 10/11/2021 | -97.43% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-10-20 11:20:00 20/10/2021 | -97.12% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-06-16 14:25:00 16/06/2021 | -96.55% |
| Watch | Richard Evans | Premium Only | 2021-06-02 08:25:00 02/06/2021 | – |